• Clinical study showed lower incidence of cerebral palsy in infants (Doyle et al., 2009). • An open-label pilot study showed that combination of MgSO4, erythropoietin and TH was found to be safe (Nonomura et al., 2019). The gene discussed is EPO; the disease is cerebral palsy.